These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 21832246
1. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy. Verhees KJ, Schols AM, Kelders MC, Op den Kamp CM, van der Velden JL, Langen RC. Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246 [Abstract] [Full Text] [Related]
2. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091 [Abstract] [Full Text] [Related]
3. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Léger B, Senese R, Al-Khodairy AW, Dériaz O, Gobelet C, Giacobino JP, Russell AP. Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653 [Abstract] [Full Text] [Related]
4. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA. Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM, Thissen JP. Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385 [Abstract] [Full Text] [Related]
5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Castillero E, Alamdari N, Lecker SH, Hasselgren PO. Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982 [Abstract] [Full Text] [Related]
6. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway. Wang XJ, Xiao JJ, Liu L, Jiao HC, Lin H. Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 29046370 [Abstract] [Full Text] [Related]
7. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes. Evenson AR, Fareed MU, Menconi MJ, Mitchell JC, Hasselgren PO. Int J Biochem Cell Biol; 2005 Oct 22; 37(10):2226-38. PubMed ID: 16051512 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms. Li BG, Hasselgren PO, Fang CH. Int J Biochem Cell Biol; 2005 Oct 22; 37(10):2207-16. PubMed ID: 15927518 [Abstract] [Full Text] [Related]
9. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. Léger B, Cartoni R, Praz M, Lamon S, Dériaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP. J Physiol; 2006 Nov 01; 576(Pt 3):923-33. PubMed ID: 16916907 [Abstract] [Full Text] [Related]
10. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. Edström E, Altun M, Hägglund M, Ulfhake B. J Gerontol A Biol Sci Med Sci; 2006 Jul 01; 61(7):663-74. PubMed ID: 16870627 [Abstract] [Full Text] [Related]
11. IGF-I activates the mouse type IIb myosin heavy chain gene. Shanely RA, Zwetsloot KA, Childs TE, Lees SJ, Tsika RW, Booth FW. Am J Physiol Cell Physiol; 2009 Oct 01; 297(4):C1019-27. PubMed ID: 19657059 [Abstract] [Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, Schols AM. Am J Physiol Cell Physiol; 2006 Feb 01; 290(2):C453-62. PubMed ID: 16162663 [Abstract] [Full Text] [Related]
13. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. Léger B, Vergani L, Sorarù G, Hespel P, Derave W, Gobelet C, D'Ascenzio C, Angelini C, Russell AP. FASEB J; 2006 Mar 01; 20(3):583-5. PubMed ID: 16507768 [Abstract] [Full Text] [Related]
15. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta. van der Velden JL, Langen RC, Kelders MC, Willems J, Wouters EF, Janssen-Heininger YM, Schols AM. Am J Physiol Cell Physiol; 2007 May 01; 292(5):C1636-44. PubMed ID: 17166938 [Abstract] [Full Text] [Related]
16. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Yoshida T, Semprun-Prieto L, Sukhanov S, Delafontaine P. Am J Physiol Heart Circ Physiol; 2010 May 01; 298(5):H1565-70. PubMed ID: 20228261 [Abstract] [Full Text] [Related]
17. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Doucet M, Russell AP, Léger B, Debigaré R, Joanisse DR, Caron MA, LeBlanc P, Maltais F. Am J Respir Crit Care Med; 2007 Aug 01; 176(3):261-9. PubMed ID: 17478621 [Abstract] [Full Text] [Related]
18. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes. Eo H, Reed CH, Valentine RJ. Biomed Pharmacother; 2020 Aug 01; 128():110238. PubMed ID: 32450522 [Abstract] [Full Text] [Related]
19. Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats. Yin HN, Chai JK, Yu YM, Shen CA, Wu YQ, Yao YM, Liu H, Liang LM, Tompkins RG, Sheng ZY. J Trauma; 2009 Apr 01; 66(4):1083-90. PubMed ID: 19359918 [Abstract] [Full Text] [Related]
20. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Frost RA, Nystrom GJ, Jefferson LS, Lang CH. Am J Physiol Endocrinol Metab; 2007 Feb 01; 292(2):E501-12. PubMed ID: 17003238 [Abstract] [Full Text] [Related] Page: [Next] [New Search]